BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

ORIONPHARM

All Eps Dividend Board Agm Q1 Q2 Q3

ORIONPHARM 05-Nov-2019

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 12, 2019 at 5:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2019.

ORIONPHARM 23-Oct-2019

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 06, 2019 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2019.

ORIONPHARM 02-May-2019

(Q3 Un-audited): Consolidated EPS was Tk. 0.95 for January-March 2019 as against Tk. 0.69 for January-March 2018; Consolidated EPS was Tk. 3.01 for July'18-March'19 as against Tk. 2.76 for July'17-March'18. Consolidated NOCFPS was Tk. 7.15 for July'18-March'19 as against Tk. 8.57 for July'17-March'18. Consolidated NAV per share (including and excluding Revaluation Surplus) was Tk. 74.29 and Tk. 66.05 respectively as on March 31, 2019 as against Tk. 72.88 and Tk. 64.55 respectively as on June 30, 2018.

ORIONPHARM 25-Apr-2019

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 30, 2019 at 5:15 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2019.

ORIONPHARM 03-Feb-2019

(Continuation news of ORIONPHARM): Consolidated NAV per share including revaluation surplus was Tk. 73.32 as on December 31, 2018 and Tk. 72.88 as on June 30, 2018. Consolidated NAV per share excluding revaluation surplus was Tk. 65.05 as on December 31, 2018 and Tk. 64.55 as on June 30, 2018. (end)

ORIONPHARM 03-Feb-2019

(Q2 Un-audited): Consolidated EPS was Tk. 1.08 for October-December, 2018 as against Tk. 0.97 for October-December, 2017; Consolidated EPS was Tk. 2.06 for July-December, 2018 as against Tk. 2.07 for July-December, 2017. Consolidated NOCFPS was Tk. 4.98 for July-December, 2018 as against Tk. 4.81 for July-December, 2017. (cont.)

ORIONPHARM 27-Jan-2019

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 31, 2019 at 5:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2018.

ORIONPHARM 20-Jan-2019

The Company has informed that it has disbursed the cash dividend for the year ended on June 30, 2018 to the respective shareholders.

ORIONPHARM 22-Nov-2018

Trading of the shares of the Company will resume on 25.11.2018 after record date.

ORIONPHARM 20-Nov-2018

Trading of the shares of the Company will remain suspended on record date i.e., 22.11.2018.

Previous Next page